ArticleNature communications2026
Multicomponent synergistic immobilization via in-situ and dynamic exchange strategies for constructing hierarchical biopharmaceuticals.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hierarchical immobilization of multicomponent biomacromolecules has been demonstrated to be a favorable protocol for constructing advanced biopharmaceuticals, but still with formidable challenges. Herein, we innovate a multicomponent synergistic immobilization approach combining an in-situ method with a structural-transformation-promoted dynamic exchange method in a flexible zeolitic pyrimidine framework (ZPF) platform to construct multicomponent biopharmaceuticals. In-depth mechanism investigation reveals that special functional groups (e.g., carboxyl, sulfhydryl, imidazolyl) on protein surface can significantly promote the dynamic structural transformation of ZPF and allow for the efficient immobilization of proteins on the surface of ZPF crystals via dynamic exchange approach. By combining with the in-situ method, which can immobilize biomacromolecules in the inner part of ZPF crystals, multicomponent biomacromolecules can be regionally localized within ZPF crystals. This controlled spatial preparation provides substantial advantages over conventional core-shell architectures for cascading enzyme immobilization and enables the development of advanced anticancer agents demonstrating enhanced therapeutic efficacy for female Balb/c nu mice. Moreover, this platform can also generate highly efficient hierarchical antibacterial formulations to significantly enhance the wound-healing process of male Sprague-Dawley (SD) rats. This study provides a revolution to immobilize multicomponent biomacromolecules and represents an innovative and effective platform of biopharmaceuticals with immense potential for anticancer and antibacterial formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.